Search PDMR transactions

Notifier
Name of person with notification obligation
Linnane Pharma AB
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Linnane Pharma AB
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Selectimmune Pharma AB
Issuer´s LEI code
549300UJSDOUNOHDHL66
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share SelectImmune Pharma serie B SE0012622785 Acquisition 16,000 Quantity 13.20 SEK 29/06/2021 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
SelectImmune Pharma serie B SE0012622785 Acquisition 29/06/2021 Outside a trading venue 16,000 (Quantity) 13.20 SEK
<< Back